Your browser doesn't support javascript.
loading
Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).
Minatogawa, Hiroko; Izawa, Naoki; Shimomura, Kazuhiro; Arioka, Hitoshi; Iihara, Hirotoshi; Sugawara, Mitsuhiro; Morita, Hajime; Mochizuki, Ayako; Nawata, Shuichi; Mishima, Keisuke; Tsuboya, Ayako; Miyaji, Tempei; Honda, Kazunori; Yokomizo, Ayako; Hashimoto, Naoya; Yanagihara, Takeshi; Endo, Junki; Kawaguchi, Takashi; Furuya, Naoki; Sone, Yumiko; Inada, Yusuke; Ohno, Yasushi; Katada, Chikatoshi; Hida, Naoya; Akiyama, Kana; Ichikura, Daisuke; Konomatsu, Akiko; Ogura, Takashi; Yamaguchi, Takuhiro; Nakajima, Takako Eguchi.
Affiliation
  • Minatogawa H; Department of Pharmacy, St. Marianna University Hospital, Kawasaki, Japan.
  • Izawa N; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Shimomura K; Department of Pharmacy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Arioka H; Department of Medical Oncology, Yokohama Rosai Hospital, Yokohama, Japan.
  • Iihara H; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
  • Sugawara M; Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Sagamihara, Japan.
  • Morita H; Department of Pharmacy, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Japan.
  • Mochizuki A; Department of gynecology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Nawata S; Department of Pharmacy, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Mishima K; Department of Digestive surgery, Nippon Medical School Musashikosugi Hospital, Kawasaki, Japan.
  • Tsuboya A; Department of Pharmacy, Kawasaki municipal Tama Hospital, Kawasaki, Japan.
  • Miyaji T; Department of Clinical Trial Data Management Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Honda K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yokomizo A; Department of Pharmacy, St. Marianna University Hospital, Kawasaki, Japan.
  • Hashimoto N; Department of Pharmacy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yanagihara T; Department of Medical Oncology, Yokohama Rosai Hospital, Yokohama, Japan.
  • Endo J; Department of Cardiology and Respiratory Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Kawaguchi T; Department of Practical Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan.
  • Furuya N; Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Sone Y; Department of Clinical Pharmacy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Inada Y; Department of Pharmacy, Yokohama Rosai Hospital, Yokohama, Japan.
  • Ohno Y; Department of Cardiology and Respiratory Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Katada C; Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Hida N; Department of Respiratory Internal Medicine, St. Marianna University Yokohama City Seibu Hospital, Yokohama, Japan.
  • Akiyama K; Department of pharmacy, Shizuoka Cancer Center, Nagaizumi, Japan.
  • Ichikura D; Department of Pharmacy, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Konomatsu A; Department of Pharmacy, Nippon Medical School Musashikosugi Hospital, Kawasaki, Japan.
  • Ogura T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Yamaguchi T; Department of Clinical Oncology, Kawasaki municipal Tama Hospital, Kawasaki, Japan.
  • Nakajima TE; Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Br J Cancer ; 130(2): 224-232, 2024 02.
Article in En | MEDLINE | ID: mdl-37973958

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiemetics / Antineoplastic Agents Limits: Humans Language: En Journal: Br J Cancer Year: 2024 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiemetics / Antineoplastic Agents Limits: Humans Language: En Journal: Br J Cancer Year: 2024 Document type: Article Affiliation country: Japón